HYPD — Hyperion DeFi Share News
0.000.00%
- $39.22m
- $38.02m
- $0.81m
Eyenovia to discontinue late-stage study for eye drug (updated)
Eyenovia to discontinue late-stage study for eye drug
Brief: Eyenovia Provides Update On Phase 3 Chaperone Study
Eyenovia Inc reports results for the quarter ended September 30 - Earnings Summary
Eyenovia Inc expected to post a loss of 13 cents a share - Earnings Preview
Brief: Eyenovia Files For Mixed Shelf Offering Of Up To $100 Million- SEC Filing
Brief: Eyenovia Announces Pricing Of $4 Million Registered Direct Offering
Brief: Eyenovia Announces Launch, Commercial Availability Of Clobetasol Propionate Ophthalmic Suspension
Brief: Eyenovia Inc Says On Sept 18, Got Notice From Nasdaq On Co's Failure To Satisfy A Continued Listing Rule Or Standard
Brief: Eyenovia Appoints Andrew Jones As Chief Financial Officer
Brief: Eyenovia Announces Proposed Public Offering
Eyenovia Inc reports results for the quarter ended in June - Earnings Summary
Eyenovia Inc expected to post a loss of 15 cents a share - Earnings Preview
Eyenovia Inc expected to post a loss of 15 cents a share - Earnings Preview
Brief: Eyenovia, Senju Pharmaceutical To Collaborate On Potential New Treatment For Chronic Dry Eye Disease
Brief: Eyenovia Announces Pricing Of $5M Registered Direct Offering
Eyenovia Inc expected to post a loss of 17 cents a share - Earnings Preview
Brief: Eyenovia Offers Certain Purchasers 3.2 Mln Shares At $0.6204 Per Share, For Purchase Price Of $2 Mln
U.S. STOCKS ON THE MOVE-Perpetua Resources, Huntington Bancshares, FuelCell Energy